7'-OH-N-trityl Morpholino thyMine is a chemically modified nucleoside analog. Its structure features a morpholino ring system replacing the natural ribose sugar, with a trityl (triphenylmethyl) protecting group on the nitrogen and a hydroxymethyl group at a specific stereochemical position. This design incorporates a thymine base, making it a key derivative in the morpholino chemistry series. This compound serves as a crucial advanced intermediate in the synthesis of Morpholino oligonucleotides (PMOs). PMOs are a class of antisense therapeutics and research tools known for their neutral backbone, which confers high binding affinity to complementary RNA sequences, resistance to nucleases, and the ability to sterically block translation or splicing. The specific modifications in this intermediate, including the protected hydroxymethyl group, are essential for the controlled, stepwise solid-phase assembly of these oligonucleotides. Its primary application is in the research and development of novel genetic medicines targeting a wide range of diseases, including genetic disorders, viral infections, and cancers. The product is a high-value building block used by specialized manufacturers and research institutions focused on oligonucleotide therapeutics and molecular biology tools.